Реестр международных мультицентровых клинических исследований лекарств в России
Study List: Étude 1: Titre: A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation Therapy Recruitment: Recruiting Study Results: No Results Available Conditions: Cancer|Cataract|Low Bone Mineral Density|Ostéopénie|Ostéoporose|Prostate Cancer Interventions: Biological: Denosumab|Biological: Placebo URL: http://ClinicalTrials.gov/show/NCT00925600 Study 2: Titre: Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection Recruitment: Recruiting Study Results: No Results Available Conditions: Intra-Abdominal Infection Interventions: Médicament: Moxifloxacine (Avelox, BAY12-8039)|Médicament: Ertapenem, Amoxicillin/clavulanate URL: http://ClinicalTrials.gov/show/NCT01069900 Study 3: Titre: A Study of LY2140023 in Patients With Schizophrenia Recruitment: Recruiting Study Results: No Results Available Conditions: Schizophrenia Interventions: Médicament: LY2140023|Médicament: Placebo URL: http://ClinicalTrials.gov/show/NCT01307800 Study 4: Titre: Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism Recruitment: Recruiting Study Results: No Results Available Conditions: Venous Thrombosis Interventions: Médicament: Enoxaparin|Médicament: warfarin|Médicament: Placebo for apixaban|Médicament: Placebo for enoxaparin|Médicament: Placebo for warfarin|Médicament: apixaban URL: http://ClinicalTrials.gov/show/NCT00643201 Study 5: Titre: LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib Recruitment: Recruiting Study Results: No Results Available Conditions: or Gastro-esophageal Junction Adenocarcinoma That is Unresectable Due to Locally Advanced Metastatic, or Locally Recurrent Disease.|ErbB2 (HER2) Amplified Gastric|Tumeurs, Gastrointestinal Tract|Esophageal Interventions: Médicament: Lapatinib|Médicament: Placebo URL: http://ClinicalTrials.gov/show/NCT00680901 Study 6: Titre: Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Advanced Breast Cancer|Breast Cancer Interventions: Médicament: Neratinib|Médicament: Lapatinib|Médicament: Capecitabine URL: http://ClinicalTrials.gov/show/NCT00777101 Study 7: Titre: An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical or Urgent Invasive Procedure Recruitment: Recruiting Study Results: No Results Available Conditions: Reversal of Coagulopathy Interventions: Biological: Beriplex® P/N|Biological: Fresh frozen plasma URL: http://ClinicalTrials.gov/show/NCT00803101 Study 8: Titre: Efficacy and Safety of Daclizumab High Yield Process Versus Interferon β 1a in Patients With Relapsing-Remitting Multiple Sclerosis Recruitment: Recruiting Study Results: No Results Available Conditions: Relapsing Remitting Multiple Sclerosis Interventions: Médicament: Interferon β 1a|Médicament: DAC HYP URL: http://ClinicalTrials.gov/show/NCT01064401 Study 9: Titre: IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma Recruitment: Recruiting Study Results: No Results Available Conditions: Metastatic Renal Cell Carcinoma Interventions: Médicament: Sunitinib|Biological: IMA901 plus GM-CSF|Médicament: Cyclophosphamide URL: http://ClinicalTrials.gov/show/NCT01265901 Study 10: Titre: A Study to Observe Real-life Allocation of Antipsychotics in Acute Inpatient Management of Schizophrenia Recruitment: Recruiting Study Results: No Results Available Conditions: Schizophrenia Interventions: URL: http://ClinicalTrials.gov/show/NCT01394601 Study 11: Titre: Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function Recruitment: Recruiting Study Results: No Results Available Conditions: Maladies cardiovasculaires|Heart Diseases|Insuffisance cardiaque, Congestive Interventions: Médicament: Aldosterone Antagonist (spironolactone)|Médicament: Placebo URL: http://ClinicalTrials.gov/show/NCT00094302 Study 12: Titre: A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial) Recruitment: Recruiting Study Results: No Results Available Conditions: Maladie, Hodgkin Interventions: Médicament: brentuximab vedotin|Médicament: placebo URL: http://ClinicalTrials.gov/show/NCT01100502 Study 13: Titre: Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures Recruitment: Recruiting Study Results: No Results Available Conditions: Saisies|Épilepsie|Partial-Onset Seizures Interventions: Médicament: Retigabine IR URL: http://ClinicalTrials.gov/show/NCT01227902 Study 14: Titre: A Rheumatoid Arthritis Study in Patients on a Background Treatment of Methotrexate Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Médicament: LY2127399|Médicament: Placebo every 2 semaines|Médicament: Placebo every 4 weeks URL: http://ClinicalTrials.gov/show/NCT01198002 Study 15: Titre: Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Metastatic Breast Cancer Interventions: Médicament: Eniluracil|Médicament: 5-Fluorouracil|Médicament: Leucovorin|Médicament: Capecitabine URL: http://ClinicalTrials.gov/show/NCT01231802 Study 16: Titre: A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine Recruitment: Recruiting Study Results: No Results Available Conditions: Tumor|Pain Interventions: Médicament: CG5503 ER|Médicament: Placebo to match CG5503|Médicament: Morphine Sulphate CR|Médicament: Placebo to match Morphine Sulphate CR URL: http://ClinicalTrials.gov/show/NCT00472303 Study 17: Titre: Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Médicament: ATN-103|Médicament: ATN-103 URL: http://ClinicalTrials.gov/show/NCT01063803 Study 18: Titre: A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia Recruitment: Recruiting Study Results: No Results Available Conditions: Lymphocytic Leukemia, Chronic Interventions: Médicament: rituximab [MabThera]|Médicament: rituximab [MabThera]|Médicament: rituximab [MabThera]|Médicament: Fludarabine|Médicament: Cyclophosphamide URL: http://ClinicalTrials.gov/show/NCT01292603 Study 19: Titre: A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection Recruitment: Recruiting Study Results: No Results Available Conditions: Chronic Hepatitis B Virus, Pediatric Interventions: Médicament: Entecavir|Médicament: Placebo URL: http://ClinicalTrials.gov/show/NCT01079806 Study 20: Titre: Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia Recruitment: Recruiting Study Results: No Results Available Conditions: Alopécie|Androgenetic Alopecia Interventions: Médicament: 1mg Finasteride active|Médicament: 0.02mg dutasteride|Médicament: 0.1mg dutasteride|Médicament: 0.5mg dutasteride|Médicament: Finasteride placebo|Médicament: Dutasteride placebo URL: http://ClinicalTrials.gov/show/NCT01231607 Study 21: Titre: Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial Recruitment: Recruiting Study Results: No Results Available Conditions: Fibrillation auriculaire|Arythmie|Stroke Prevention|Mortality Interventions: Device: Left atrial ablation|Médicament: Rate or Rhythm Control Therapy URL: http://ClinicalTrials.gov/show/NCT00911508 Study 22: Titre: Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome Recruitment: Recruiting Study Results: No Results Available Conditions: Diabète sucré, Taper 2|Acute Coronary Syndrome Interventions: Médicament: Alogliptin|Médicament: Placebo URL: http://ClinicalTrials.gov/show/NCT00968708 Study 23: Titre: Evaluation of Tiotropium 2.5 et 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I Recruitment: Recruiting Study Results: No Results Available Conditions: Asthma Interventions: Médicament: Placebo|Médicament: Placebo|Médicament: Placebo|Médicament: Placebo|Médicament: Placebo|Médicament: 50 mcg salmeterol HFA MDI|Médicament: 5 mcg tiotropium Respimat®|Médicament: 2.5 mcg tiotropium Respimat® URL: http://ClinicalTrials.gov/show/NCT01172808 Study 24: Titre: Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma Recruitment: Recruiting Study Results: No Results Available Conditions: Hepatocellular Carcinoma Interventions: Médicament: sorafenib|Biological: mapatumumab URL: http://ClinicalTrials.gov/show/NCT01258608 Study 25: Titre: Study Of Letrozole With Or Without PD 0332991 For The First-Line Treatment Of Hormone-Receptor Positive Advanced Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Breast Cancer Interventions: Médicament: PD 0332991|Médicament: letrozole|Médicament: letrozole URL: http://ClinicalTrials.gov/show/NCT00721409 Study 26: Titre: Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin Recruitment: Recruiting Study Results: No Results Available Conditions: Cancer du poumon - Non Small Cell Interventions: Médicament: Ipilimumab|Médicament: Placebo|Médicament: Paclitaxel|Médicament: Carboplatin URL: http://ClinicalTrials.gov/show/NCT01285609 Study 27: Titre: Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients Recruitment: Recruiting Study Results: No Results Available Conditions: Alzheimer Disease Interventions: Médicament: bapineuzumab|Médicament: bapineuzumab|Médicament: placebo URL: http://ClinicalTrials.gov/show/NCT00667810 Study 28: Titre: Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial) Recruitment: Recruiting Study Results: No Results Available Conditions: B-Cell Chronic Lymphocytic Leukemia (B-CLL) Interventions: Médicament: Lenalidomide|Médicament: Chlorambucil URL: http://ClinicalTrials.gov/show/NCT00910910 Study 29: Titre: A Study of MabThera (Rituximab) in Combination With Fludarabine and Cyclophosphamide in Patients With Chronic Lymphocytic Leukemia And Favorable Somatic Status Recruitment: Recruiting Study Results: No Results Available Conditions: Lymphocytic Leukemia, Chronic Interventions: Médicament: rituximab [MabThera]|Médicament: fludarabine|Médicament: cyclophosphamide URL: http://ClinicalTrials.gov/show/NCT01271010 Study 30: Titre: A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Tumeurs, Breast Interventions: Médicament: lapatinib|Médicament: trastuzumab|Médicament: Aromatase inhibitor|Médicament: lapatinib URL: http://ClinicalTrials.gov/show/NCT01160211 Study 31: Titre: A Long-Term, Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee Recruitment: Recruiting Study Results: No Results Available Conditions: Osteoarthritis Interventions: Médicament: SD-6010|Médicament: SD-6010|Médicament: Placebo URL: http://ClinicalTrials.gov/show/NCT00565812 Study 32: Titre: Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroids Recruitment: Not yet recruiting Study Results: No Results Available Conditions: Asthma Interventions: Médicament: Placebo matching Respimat|Médicament: Placebo matching Respimat|Médicament: BI 54903 MARYLAND|Médicament: BI 54903 HD URL: http://ClinicalTrials.gov/show/NCT01458912 Study 33: Titre: Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure Recruitment: Recruiting Study Results: No Results Available Conditions: Heart Failure Interventions: Médicament: Placebo|Médicament: Omecamtiv mecarbil URL: http://ClinicalTrials.gov/show/NCT01300013 Study 34: Titre: Study of Immunotherapy to Treat Advanced Prostate Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Prostate Cancer Interventions: Médicament: Ipilimumab|Médicament: Placebo URL: http://ClinicalTrials.gov/show/NCT00861614 Study 35: Titre: Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin Recruitment: Recruiting Study Results: No Results Available Conditions: Non-small Cell Lung Cancer Interventions: Médicament: Tavocept(BNP7787) in combination with cisplatin and either docetaxel or paclitaxel|Médicament: Placebo in combination with cisplatin and docetaxel or paclitaxel URL: http://ClinicalTrials.gov/show/NCT00966914 Study 36: Titre: An Efficacy, Sécurité, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment Recruitment: Recruiting Study Results: No Results Available Conditions: Diabète sucré, Taper 2|Renal Insufficiency Interventions: Médicament: Canagliflozin 100 mg|Médicament: Canagliflozin 300 mg|Médicament: Placebo URL: http://ClinicalTrials.gov/show/NCT01064414 Study 37: Titre: ACT-293987 in Pulmonary Arterial Hypertension Recruitment: Recruiting Study Results: No Results Available Conditions: Pulmonary Arterial Hypertension Interventions: Médicament: ACT-293987|Médicament: Placebo URL: http://ClinicalTrials.gov/show/NCT01106014 Study 38: Titre: A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Médicament: tocilizumab [RoActemra/Actemra]|Médicament: tocilizumab [RoActemra/Actemra]|Médicament: placebo|Médicament: placebo|Médicament: Disease-modifying antirheumatic drugs (DMARD) URL: http://ClinicalTrials.gov/show/NCT01194414 Study 39: Titre: Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA) Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Médicament: Fostamatinib|Médicament: Fostamatinib|Médicament: Fostamatinib URL: http://ClinicalTrials.gov/show/NCT01242514 Study 40: Titre: RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial Recruitment: Recruiting Study Results: No Results Available Conditions: Insuffisance cardiaque|Anémie|Maladie cardiovasculaire|Ventricular Dysfunction|Congestive Heart Failure Interventions: Médicament: Darbepoetin alfa|Médicament: Placebo URL: http://ClinicalTrials.gov/show/NCT00358215 Study 41: Titre: AVAPERL1 Study: A Study of Avastin (Bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small Cell Lung Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Non-Small Cell Lung Cancer Interventions: Médicament: bevacizumab [j'ai découvert]|Médicament: pemetrexed|Médicament: cisplatin URL: http://ClinicalTrials.gov/show/NCT00961415 Study 42: Titre: Study of ACT-129968 in Adult Patients With Partly Controlled Asthma. Recruitment: Recruiting Study Results: No Results Available Conditions: Asthma Interventions: Médicament: ACT-129968|Médicament: Placebo URL: http://ClinicalTrials.gov/show/NCT01225315 Study 43: Titre: A Study of Ixabepilone as Second Line Therapy for Locally Advanced, Recurrent or Metastatic Endometrial Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Endometrial Cancer Interventions: Médicament: Ixabepilone|Médicament: Doxorubicine|Médicament: Paclitaxel URL: http://ClinicalTrials.gov/show/NCT00883116 Study 44: Titre: Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Kidney Neoplasms Interventions: Médicament: Axitinib (AG-013736)|Médicament: Sorafenib URL: http://ClinicalTrials.gov/show/NCT00920816 Study 45: Titre: A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults Recruitment: Recruiting Study Results: No Results Available Conditions: Infection, Human Immunodeficiency Virus Interventions: Médicament: GSK1349572|Médicament: Raltegravir|Médicament: GSK1349572 Placebo|Médicament: Raltegravir Placebo URL: http://ClinicalTrials.gov/show/NCT01231516 Study 46: Titre: A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients Recruitment: Recruiting Study Results: No Results Available Conditions: Hepatitis C Interventions: Médicament: PegIFN/RBV|Médicament: BI 201335 URL: http://ClinicalTrials.gov/show/NCT01330316 Study 47: Titre: Effect of Multiple Infusions of AIN457 on Disease Activity in Relapsing-remitting Multiple Sclerosis Recruitment: Recruiting Study Results: No Results Available Conditions: Sclérose en plaques|Relapsing-remitting Interventions: Médicament: AIN457|Médicament: Placebo URL: http://ClinicalTrials.gov/show/NCT01051817 Study 48: Titre: A Study of the Efficacy and Safety of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine Treatment (H1) Recruitment: Recruiting Study Results: No Results Available Conditions: Chronic Idiopathic Urticaria Interventions: Médicament: omalizumab|Médicament: placebo URL: http://ClinicalTrials.gov/show/NCT01287117 Study 49: Titre: Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections Recruitment: Recruiting Study Results: No Results Available Conditions: Mycoses|Candidose, Invasive|Candidemia Interventions: Médicament: Isavuconazole|Médicament: Caspofungin|Médicament: Voriconazole URL: http://ClinicalTrials.gov/show/NCT00413218 Study 50: Titre: BIBF 1120 or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Ovarian Neoplasms|Peritoneal Neoplasms Interventions: Médicament: BIBF 1120|Médicament: Placebo URL: http://ClinicalTrials.gov/show/NCT01015118 Study 51: Titre: An Immunogenicity and Pharmacokinetics (PK) Study of DAC HYP Prefilled Syringe in Relapsing Remitting Multiple Sclerosis (SEP-RR) Recruitment: Recruiting Study Results: No Results Available Conditions: Relapsing Remitting Multiple Sclerosis Interventions: Biological: Daclizumab High Yield Process prefilled syringe URL: http://ClinicalTrials.gov/show/NCT01462318 Study 52: Titre: Study in Adolescents With Schizophrenia or Bipolar Disorder Recruitment: Recruiting Study Results: No Results Available Conditions: Bipolar I Disorder|Schizophrenia Interventions: Médicament: Olanzapine|Behavioral: Standard behavioral weight intervention|Behavioral: Intense behavioral weight intervention URL: http://ClinicalTrials.gov/show/NCT00982020 Study 53: Titre: ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation Recruitment: Recruiting Study Results: No Results Available Conditions: Coronary Artery Disease Interventions: Médicament: RVX000222|Médicament: Placebo RVX000222 URL: http://ClinicalTrials.gov/show/NCT01067820 Study 54: Titre: A Study of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (NN25307) Recruitment: Recruiting Study Results: No Results Available Conditions: Schizophrenia Interventions: Médicament: RO4917838|Médicament: RO4917838|Médicament: Placebo URL: http://ClinicalTrials.gov/show/NCT01235520 Study 55: Titre: Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Subjects With PHPT Unable to Undergo Parathyroidectomy Recruitment: Recruiting Study Results: No Results Available Conditions: Hyperparathyroïdie, Primary Interventions: Médicament: cinacalcet HCl|Médicament: Placebo URL: http://ClinicalTrials.gov/show/NCT00975221 Study 56: Titre: Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Not Responding. Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Médicament: fostamatinib|Médicament: fostamatinib|Médicament: placebo, fostamatinib URL: http://ClinicalTrials.gov/show/NCT01197521 Study 57: Titre: Long-Term Safety Study of Retigabine Immediate Release (ET) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS). Recruitment: Recruiting Study Results: No Results Available Conditions: Saisies|Épilepsie|Partial-Onset Seizures Interventions: Médicament: Retigabine IR URL: http://ClinicalTrials.gov/show/NCT01336621 Study 58: Titre: Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer. Recruitment: Recruiting Study Results: No Results Available Conditions: Metastatic Breast Cancer|Metastases, Brain Interventions: Médicament: capecitabine|Médicament: lapatinib|Médicament: trastuzumab URL: http://ClinicalTrials.gov/show/NCT00820222 Study 59: Titre: STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction Recruitment: Recruiting Study Results: No Results Available Conditions: Myocardial Infarction Interventions: Médicament: tenecteplase|Médicament: enoxaparin|Médicament: clopidogrel|Procédure: catheterisation|Procédure: primary PCI URL: http://ClinicalTrials.gov/show/NCT00623623 Study 60: Titre: A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis Recruitment: Recruiting Study Results: No Results Available Conditions: Sclérose en plaques, Relapsing-Remitting Interventions: Médicament: ocrélizumab|Médicament: Rebif|Médicament: ocrelizumab placebo|Médicament: Rebif placebo URL: http://ClinicalTrials.gov/show/NCT01247324 Study 61: Titre: CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes Recruitment: Recruiting Study Results: No Results Available Conditions: Diabète sucré, Taper 2 Interventions: Médicament: linagliptin|Médicament: glimepiride URL: http://ClinicalTrials.gov/show/NCT01243424 Study 62: Titre: PANORAMA Observational Study Recruitment: Recruiting Study Results: No Results Available Conditions: Arythmie|Cardiac Pacemaker, Artificial|Defibrillators, Implantable Interventions: Device: Cardiac Pacemaker, Defibrillator, pacemaker lead URL: http://ClinicalTrials.gov/show/NCT00382525 Study 63: Titre: GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Tumor Antigen-positive Non-Small Cell Lung Cancer|Cancer du poumon, Non-Small Cell Interventions: Biological: GSK1572932A Antigen-Specific Cancer Immunotherapeutic|Biological: Placebo Control URL: http://ClinicalTrials.gov/show/NCT00480025 Study 64: Titre: A Study of the Quality of Life and Treatment Response to Once Weekly NeoRecormon (Epoetin Beta) Treatment in Anemic Patients With Solid and Lymphoid Malignancies. Recruitment: Recruiting Study Results: No Results Available Conditions: Anemia Interventions: Médicament: epoetin beta [NeoRecormon]|Médicament: epoetin beta [NeoRecormon] URL: http://ClinicalTrials.gov/show/NCT00776425 Study 65: Titre: Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (TEV) in Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Venous Thromboembolism Interventions: Médicament: Warfarin|Médicament: Innohep® URL: http://ClinicalTrials.gov/show/NCT01130025 Study 66: Titre: Combivir And Maraviroc In Antiretroviral Naive Subjects In Russia Recruitment: Recruiting Study Results: No Results Available Conditions: HIV Interventions: Médicament: HIV therapy URL: http://ClinicalTrials.gov/show/NCT01275625 Study 67: Titre: LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures Recruitment: Recruiting Study Results: No Results Available Conditions: Breast Neoplasms Interventions: Médicament: Afatinib 40mg once daily (OD)|Médicament: Vinorelbine 25 mg/m2 weekly|Médicament: Paclitaxel 80 mg/m2 weekly URL: http://ClinicalTrials.gov/show/NCT01271725 Study 68: Titre: A Study of Onartuzumab (MetMAb) in Combination With Tarceva (Erlotinib) in Patients With Met Diagnostic-Positive Non-Small Cell Lung Cancer Who Have Received Chemotherapy For Advanced or Metastatic Disease (MetLung) Recruitment: Not yet recruiting Study Results: No Results Available Conditions: Non-Small Cell Lung Cancer Interventions: Médicament: onartuzumab [MetMAb]|Médicament: erlotinib [Tarceva]|Médicament: Placebo URL: http://ClinicalTrials.gov/show/NCT01456325 Study 69: Titre: Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Breast Cancer Interventions: Biological: ramucirumab (IMC-1121B)|Médicament: docetaxel|Autre: placebo URL: http://ClinicalTrials.gov/show/NCT00703326 Study 70: Titre: ACT-128800 in Patients With Relapsing-remitting Multiple Sclerosis -Extension Study Recruitment: Recruiting Study Results: No Results Available Conditions: Relapsing-remitting Multiple Sclerosis Interventions: Médicament: ACT-128800|Médicament: ACT-128800|Médicament: ACT-128800 URL: http://ClinicalTrials.gov/show/NCT01093326 Study 71: Titre: A Double-blind, Placebo-controlled, 2-year Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease. Recruitment: Recruiting Study Results: No Results Available Conditions: Maladie d'Alzheimer|Démence, Alzheimer Type Interventions: Médicament: Galantamine|Médicament: Placebo URL: http://ClinicalTrials.gov/show/NCT00679627 Study 72: Titre: A Study of the Safety and Efficacy of Ustekinumab in Adolescent Patients With Psoriasis (CADMUS) Recruitment: Recruiting Study Results: No Results Available Conditions: Psoriasis Interventions: Biological: ustekinumab/placebo|Biological: ustekinumab/placebo|Biological: ustekinumab/placebo URL: http://ClinicalTrials.gov/show/NCT01090427 Study 73: Titre: PEARL Schizophrenia Maintenance Recruitment: Recruiting Study Results: No Results Available Conditions: Schizophrenia Interventions: Médicament: Lurasidone|Médicament: Matching Placebo URL: http://ClinicalTrials.gov/show/NCT01435928 Study 74: Titre: Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery Recruitment: Recruiting Study Results: No Results Available Conditions: Preterm Birth Interventions: Médicament: Hydroxyprogesterone Caproate Injection, 250mg/mL|Médicament: Vehicle URL: http://ClinicalTrials.gov/show/NCT01004029 Study 75: Titre: A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment Recruitment: Recruiting Study Results: No Results Available Conditions: Diabète sucré, Taper 2 Interventions: Médicament: aleglitazar|Médicament: pioglitazone URL: http://ClinicalTrials.gov/show/NCT01043029 Study 76: Titre: Roflumilast in Chronic Obstructive Pulmonary Disease (BPCO) Patients Treated With Fixed Combinations of Long-acting β2-agonists (DEUX) and Inhaled Glucocorticosteroid (SCI) Recruitment: Recruiting Study Results: No Results Available Conditions: Chronic Obstructive Pulmonary Disease Interventions: Médicament: Roflumilast|Médicament: Placebo URL: http://ClinicalTrials.gov/show/NCT01329029 Study 77: Titre: A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+RO5072759 (GA101) in Patients With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma Recruitment: Recruiting Study Results: No Results Available Conditions: Non-Hodgkin's Lymphoma Interventions: Médicament: bendamustine|Médicament: RO5072759 URL: http://ClinicalTrials.gov/show/NCT01059630 Study 78: Titre: Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma Recruitment: Recruiting Study Results: No Results Available Conditions: Asthma Interventions: Médicament: 2.5 mcg tiotropium Respimat|Médicament: placebo Respimat|Médicament: 2.5 mcg tiotropium Respimat URL: http://ClinicalTrials.gov/show/NCT01257230 Study 79: Titre: TMC125IFD3002 - The VIOLIN Study: to EValuate Etravirine TolerabIlity, PharmacOkinetics With Other AntiretroviraLs In TreatmeNt Experienced Patients Recruitment: Recruiting Study Results: No Results Available Conditions: HIV Interventions: Médicament: etravirine URL: http://ClinicalTrials.gov/show/NCT01422330 Study 80: Titre: Study of Paclitaxel in Patients With Ovarian Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Epithelial Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer Interventions: Médicament: Paclical®|Médicament: Taxol® URL: http://ClinicalTrials.gov/show/NCT00989131 Study 81: Titre: A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Ovarian Cancer Interventions: Médicament: bevacizumab [j'ai découvert]|Médicament: carboplatin|Médicament: Paclitaxel URL: http://ClinicalTrials.gov/show/NCT01239732 Study 82: Titre: Asthma in Children Recruitment: Recruiting Study Results: No Results Available Conditions: Asthma Interventions: URL: http://ClinicalTrials.gov/show/NCT01286532 Study 83: Titre: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor. Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Médicament: rituximab [MabThera/Rituxan]|Médicament: Methotrexate URL: http://ClinicalTrials.gov/show/NCT00576433 Study 84: Titre: A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis Recruitment: Recruiting Study Results: No Results Available Conditions: Sclérose en plaques, Relapsing-Remitting Interventions: Médicament: ocrélizumab|Médicament: Rebif|Médicament: ocrelizumab placebo|Médicament: Rebif placebo URL: http://ClinicalTrials.gov/show/NCT01412333 Study 85: Titre: Study of Carboplatin/Paclitaxel in Combination With ABT-869 in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Recruitment: Recruiting Study Results: No Results Available Conditions: Advanced or Metastatic Non-Small Cell Lung Cancer Interventions: Médicament: ABT-869|Médicament: Placebo for ABT-869|Médicament: ABT-869 URL: http://ClinicalTrials.gov/show/NCT00716534 Study 86: Titre: Observational Program to Assess Use of Intermittent Adjuvant Deprivation Therapy With Lucrin Depot in Patients With Advanced Prostate Cancer in Russia Recruitment: Recruiting Study Results: No Results Available Conditions: Prostate Cancer Interventions: URL: http://ClinicalTrials.gov/show/NCT01320735 Study 87: Titre: A Study of the Safety and Efficacy of CNTO 328 in Combination With Best Supportive Care Compared to Best Supportive Care in Patients With Multicentric Castleman's Disease Recruitment: Recruiting Study Results: No Results Available Conditions: Castleman's Disease Interventions: Autre: Placebo|Médicament: CNTO 328 URL: http://ClinicalTrials.gov/show/NCT01024036 Study 88: Titre: Evaluation of SAR153191(REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients Recruitment: Recruiting Study Results: No Results Available Conditions: Rheumatoid Arthritis Interventions: Médicament: SAR153191 (REGN88)|Médicament: placebo URL: http://ClinicalTrials.gov/show/NCT01061736 Study 89: Titre: A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids Recruitment: Recruiting Study Results: No Results Available Conditions: Kidney Transplantation Interventions: Médicament: Advagraf|Médicament: Mycophenolate Mofetil|Médicament: Simulect|Médicament: Corticosteroids URL: http://ClinicalTrials.gov/show/NCT01304836 Study 90: Titre: Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicine, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicine, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma Recruitment: Recruiting Study Results: No Results Available Conditions: Mantle Cell Lymphoma Interventions: Médicament: Rituximab, Cyclophosphamide, Doxorubicine, VELCADE, and Prednisone|Médicament: Rituximab, Cyclophosphamide, Doxorubicine, Vincristine and Prednisone URL: http://ClinicalTrials.gov/show/NCT00722137 Study 91: Titre: A Double-blind, Randomized Controlled Study in CD20-positive Diffuse B Cell Non-Hodgkin's Lymphoma Subjects Recruitment: Recruiting Study Results: No Results Available Conditions: DLBCL Interventions: Biological: TL011|Biological: Rituximab URL: http://ClinicalTrials.gov/show/NCT01205737 Study 92: Titre: Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast Cancer Recruitment: Recruiting Study Results: No Results Available Conditions: Breast Cancer Interventions: Médicament: Sorafenib(Nexavar, BAY43-9006) / Capecitabine|Médicament: Placebo / Capecitabine URL: http://ClinicalTrials.gov/show/NCT01234337 Study 93: Titre: A Study of RoActemra/Actemra (Tocilizumab) in Comparison to Etanercept in Patients With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors Recruitment: Recruiting Study Results: No Results Available Conditions: Maladie cardiovasculaire, Rheumatoid Arthritis Interventions: Médicament: tocilizumab [RoActemra/Actemra]|Médicament: etanercept URL: http://ClinicalTrials.gov/show/NCT01331837 Study 94: Titre: Pregabalin Versus Levetiracetam In Partial Seizures Recruitment: Recruiting Study Results: No Results Available Conditions: Partial Seizures Interventions: Médicament: pregabalin|Médicament: levetiracetam URL: http://ClinicalTrials.gov/show/NCT00537238 Study 95: Titre: A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis Recruitment: Recruiting Study Results: No Results Available Conditions: Parkinson's Disease Psychosis Interventions: Médicament: pimavanserin tartrate (ACP-103) URL: http://ClinicalTrials.gov/show/NCT00550238 Study 96: Titre: Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Recruitment: Recruiting Study Results: No Results Available Conditions: Taper 2 Diabetes Mellitus Interventions: Médicament: Exenatide Once Weekly|Médicament: Placebo URL: http://ClinicalTrials.gov/show/NCT01144338 Study 97: Titre: A Study of LY2127399 in Patients With Systemic Lupus Erythematosus Recruitment: Recruiting Study Results: No Results Available Conditions: Lupus érythémateux systémique|Maladie du tissu conjonctif|Autoimmune Disease Interventions: Médicament: LY2127399|Médicament: Placebo every 2 semaines|Médicament: Placebo every 4 weeks URL: http://ClinicalTrials.gov/show/NCT01205438 Study 98: Titre: Study of FP-1039 in Subjects With Endometrial Cancers Recruitment: Recruiting Study Results: No Results Available Conditions: Endometrial Cancers With FGFR2 Mutations Interventions: Médicament: FP-1039 URL: http://ClinicalTrials.gov/show/NCT01244438 Study 99: Titre: TMC435HPC3007 - Phase III Trial of TMC435 in Genotype 1 Hepatitis C-infected Patients Who Relapsed After Previous Therapy Recruitment: Recruiting Study Results: No Results Available Conditions: Hepatitis C Interventions: Médicament: TMC435|Médicament: Placebo URL: http://ClinicalTrials.gov/show/NCT01281839 Study 100: Titre: Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line Chemotherapy Recruitment: Recruiting Study Results: No Results Available Conditions: Colorectal Cancer Interventions: Médicament: CS-7017|Médicament: Placebo URL: http://ClinicalTrials.gov/show/NCT00986440
Vous souhaitez savoir si les programmes cliniques actuels, développements de la recherche, ou des approches thérapeutiques émergentes peuvent être pertinentes à votre situation?
Informations pédagogiques et de recherche uniquement. Les décisions médicales individuelles doivent être prises en consultation avec des professionnels de santé qualifiés..
